Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › WA › RENTON › KAISER FOUNDATION HEALTH PLAN OF WASHINGTON

KAISER FOUNDATION HEALTH PLAN OF WASHINGTON

NPI: 1285805119 · RENTON, WA 98057 · Clinical Medical Laboratory · NPI assigned 03/19/2008

$11.76M
Total Medicaid Paid
623,724
Total Claims
599,730
Beneficiaries
176
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialBARLOW, MICHELLE (MANAGER)
Parent OrganizationKAISER FOUNDATION HEALTH PLAN OF WASHINGTON
NPI Enumeration Date03/19/2008

Related Entities

Other providers sharing the same authorized official: BARLOW, MICHELLE

ProviderCityStateTotal Paid
KAISER FOUNDATION HEALTH PLAN OF WASHINGTON RENTON WA $7.54M
KAISER FOUNDATION HEALTH PLAN OF WASHINGTON RENTON WA $1.30M
KAISER FOUNDATION HEALTH PLAN OF WASHINGTON SEATTLE WA $484K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 65,681 $1.01M
2019 82,809 $1.41M
2020 80,054 $1.84M
2021 115,952 $2.75M
2022 114,480 $2.23M
2023 116,036 $1.78M
2024 48,712 $744K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 26,381 24,276 $2.16M
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 20,146 18,819 $826K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 20,105 18,781 $820K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 7,279 7,072 $813K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 9,945 9,676 $617K
84443 Thyroid stimulating hormone (TSH) 27,134 26,625 $430K
80061 Lipid panel 22,359 22,044 $305K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 11,876 11,677 $287K
88305 Level IV - Surgical pathology, gross and microscopic examination 5,226 5,093 $274K
83036 Hemoglobin; glycosylated (A1C) 33,479 33,084 $267K
80050 General health panel 7,073 7,021 $246K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 31,828 30,453 $245K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 5,972 5,923 $215K
80053 Comprehensive metabolic panel 21,231 20,462 $215K
82728 15,213 14,916 $207K
87086 Culture, bacterial; quantitative colony count, urine 22,517 20,843 $181K
86003 1,563 1,384 $157K
82607 9,810 9,676 $147K
88142 5,730 5,689 $139K
86803 9,017 8,904 $127K
84403 4,866 4,084 $124K
80081 1,491 1,474 $117K
82274 6,697 6,650 $112K
86480 1,775 1,755 $108K
83550 12,337 12,111 $108K
87077 11,207 10,644 $98K
80048 Basic metabolic panel (calcium, ionized) 11,347 10,936 $93K
82565 16,716 16,241 $88K
83540 12,417 12,185 $80K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 12,672 12,505 $78K
83970 1,845 1,792 $74K
87186 8,080 7,655 $73K
85027 10,073 9,675 $65K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 774 762 $62K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 803 753 $51K
87070 5,602 5,257 $49K
86140 9,274 8,825 $49K
82043 8,315 8,232 $49K
82784 3,436 3,306 $46K
84439 5,094 4,898 $45K
84460 8,348 8,098 $45K
82672 2,081 2,035 $44K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 472 467 $44K
84702 2,887 2,390 $43K
84132 8,846 8,674 $43K
83516 3,335 3,100 $42K
83001 2,229 2,200 $42K
87081 6,008 5,912 $40K
84402 1,513 1,439 $39K
81001 12,071 11,499 $39K
84146 1,970 1,913 $39K
86592 8,562 8,417 $37K
84450 6,910 6,690 $36K
82746 2,305 2,274 $34K
82570 6,496 6,295 $33K
87210 5,988 5,793 $33K
87340 3,015 2,965 $31K
86038 2,533 2,476 $31K
86235 896 546 $30K
80076 3,650 3,549 $30K
86706 2,707 2,669 $29K
85610 6,387 4,369 $27K
87529 387 374 $26K
87338 1,762 1,750 $25K
87209 1,363 1,329 $25K
81420 Fetal chromosomal aneuploidy genomic sequence analysis panel 81 80 $24K
86200 1,805 1,793 $24K
87536 253 244 $21K
84295 4,294 4,220 $21K
83002 1,101 1,087 $21K
83880 535 517 $20K
87040 1,364 1,132 $20K
87427 1,565 1,542 $19K
83735 2,604 2,479 $17K
84153 913 897 $17K
87632 85 84 $17K
82105 1,024 1,011 $16K
87045 1,639 1,613 $16K
87046 1,607 1,582 $15K
83993 790 777 $15K
82670 493 486 $15K
G0103 Prostate cancer screening; prostate specific antigen test (psa) 736 732 $14K
82310 2,571 2,518 $13K
87177 1,362 1,328 $12K
87522 Neg quan hep c or qual rna 260 255 $12K
86704 980 960 $11K
87493 307 305 $11K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 395 393 $11K
84550 2,424 2,363 $11K
86696 523 513 $10K
81003 4,149 4,073 $9K
85652 3,199 3,090 $9K
80069 1,014 891 $9K
84156 2,347 2,162 $8K
82533 523 502 $8K
86431 1,414 1,403 $8K
84165 713 684 $8K
83520 411 400 $8K
82950 1,470 1,459 $7K
86695 525 515 $7K
83655 520 511 $6K
82947 1,506 1,461 $6K
86376 424 415 $6K
82550 898 832 $6K
84480 398 386 $6K
86225 407 397 $5K
86787 432 430 $5K
88342 95 92 $5K
87147 788 768 $5K
88304 166 162 $4K
81507 12 12 $4K
83690 583 578 $4K
82627 229 229 $4K
86160 170 158 $4K
84520 904 848 $4K
86780 261 251 $3K
84100 768 722 $3K
87329 276 268 $3K
82977 545 507 $3K
84630 248 247 $3K
88141 175 174 $2K
82374 440 431 $2K
86361 77 75 $2K
84144 107 97 $2K
85014 864 849 $2K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 33 33 $2K
83921 99 98 $2K
87280 130 129 $2K
86430 278 275 $2K
82951 116 115 $2K
80178 270 250 $2K
87220 385 375 $2K
85018 752 738 $2K
84425 112 112 $2K
84160 291 279 $2K
87088 197 191 $2K
86765 138 135 $1K
87517 27 24 $1K
82040 258 242 $1K
86762 90 89 $1K
82785 95 94 $1K
86593 262 253 $1K
83021 39 39 $952.86
87279 63 56 $947.02
85730 178 170 $924.20
82150 128 127 $876.93
83615 137 129 $856.81
87260 58 57 $833.02
83718 96 95 $811.54
82247 129 120 $641.86
84155 179 175 $628.43
85007 140 137 $538.93
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 14 14 $537.74
82465 115 114 $533.15
83521 17 12 $526.86
87101 63 63 $498.97
86735 42 40 $489.06
81015 162 157 $484.53
86708 38 37 $465.93
84075 74 69 $382.28
83498 12 12 $326.28
84134 25 25 $324.88
86800 25 25 $320.21
80051 39 38 $290.34
86308 53 51 $282.36
83883 13 12 $274.57
86334 12 12 $267.05
82378 15 12 $263.25
82172 12 12 $230.34
82525 17 17 $201.02
82390 12 12 $137.64
89055 25 25 $132.50
82248 25 25 $116.92
86255 13 12 $113.79
83721 14 14 $98.39
85045 12 12 $43.76